Trial Outcomes & Findings for Patient Satisfaction With Propofol for Out Patient Colonoscopy (NCT NCT02937506)

NCT ID: NCT02937506

Last Updated: 2017-12-26

Results Overview

Satisfaction assessed using self-developed questionnaire.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

600 participants

Primary outcome timeframe

Patient satisfaction was assessed the day of the procedure.

Results posted on

2017-12-26

Participant Flow

Participant milestones

Participant milestones
Measure
Propofol
Patients in the treatment arm will be given propofol only when having a colonoscopy. Propofol: The intervention is to use propofol as anesthesia during a colonoscopy.
Fentanyl Plus Midazolam Only
Patients in the control arm will receive only the standard of care medications, fentanyl and midazolam when having a colonoscopy. Fentanyl Plus Midazolam: The control is to use standard of care anesthesia, fentanyl and midazolam, during a colonoscopy.
Overall Study
STARTED
300
300
Overall Study
COMPLETED
300
300
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Patient Satisfaction With Propofol for Out Patient Colonoscopy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Propofol
n=300 Participants
Patients in the treatment arm will be given propofol only when having a colonoscopy. Propofol: The intervention is to use propofol as anesthesia during a colonoscopy.
Fentanyl Plus Midazolam Only
n=300 Participants
Patients in the control arm will receive only the standard of care medications, fentanyl and midazolam when having a colonoscopy. Fentanyl Plus Midazolam: The control is to use standard of care anesthesia, fentanyl and midazolam, during a colonoscopy.
Total
n=600 Participants
Total of all reporting groups
Age, Continuous
61.4 Years
STANDARD_DEVIATION 9.8 • n=5 Participants
61.0 Years
STANDARD_DEVIATION 9.4 • n=7 Participants
61.2 Years
STANDARD_DEVIATION 9.6 • n=5 Participants
Sex: Female, Male
Female
138 Participants
n=5 Participants
147 Participants
n=7 Participants
285 Participants
n=5 Participants
Sex: Female, Male
Male
162 Participants
n=5 Participants
153 Participants
n=7 Participants
315 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Patient satisfaction was assessed the day of the procedure.

Population: Same as enrolled.

Satisfaction assessed using self-developed questionnaire.

Outcome measures

Outcome measures
Measure
Propofol
n=300 Participants
Patients in the treatment arm will be given propofol only when having a colonoscopy. Propofol: The intervention is to use propofol as anesthesia during a colonoscopy.
Fentanyl Plus Midazolam Only
n=300 Participants
Patients in the control arm will receive only the standard of care medications, fentanyl and midazolam when having a colonoscopy. Fentanyl Plus Midazolam: The control is to use standard of care anesthesia, fentanyl and midazolam, during a colonoscopy.
Patient Satisfaction
Very Satisfied
259 Participants
222 Participants
Patient Satisfaction
Satisfied
37 Participants
66 Participants
Patient Satisfaction
Neutral/Less than satisfied
4 Participants
12 Participants

Adverse Events

Propofol

Serious events: 0 serious events
Other events: 7 other events
Deaths: 0 deaths

Fentanyl Plus Midazolam Only

Serious events: 0 serious events
Other events: 17 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Propofol
n=300 participants at risk
Patients in the treatment arm will be given propofol only when having a colonoscopy. Propofol: The intervention is to use propofol as anesthesia during a colonoscopy.
Fentanyl Plus Midazolam Only
n=300 participants at risk
Patients in the control arm will receive only the standard of care medications, fentanyl and midazolam when having a colonoscopy. Fentanyl Plus Midazolam: The control is to use standard of care anesthesia, fentanyl and midazolam, during a colonoscopy.
Gastrointestinal disorders
Nausea/Emesis
2.3%
7/300 • Number of events 300
5.7%
17/300 • Number of events 300

Additional Information

Anantha Padmanabhan, MD

Mount Carmel Health System

Phone: 614-234-1079

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place